Why does growth stall in high-growth potential, second-stage companies, and can we intervene to overcome this?
This research seeks to address why growth rates so often peter out in adolescent firms, and why so few make it to “grownup” status.
IGL Trials
IGL is undertaking and supporting a number of randomised controlled trials globally.
